Given the known roles that zinc deficiency plays in the physiology of insulin homeostasis and lipid metabolism, it is not surprising that several studies have reported positive effects of zinc supplementation on the risk of T2D and CVD (16, 42–44). The gene discussed is INS; the disease is Zinc deficiency.